LOAC Longevity Acquisition Corporation

Longevity Acquisition Corporation focuses on acquiring, engaging in a share exchange, share reconstruction and amalgamation, purchasing of assets, entering into contractual arrangements, or other business combination with one or more businesses. The company is based in Shanghai, the People's Republic of China.

On 10/22/2020 the company announced a pending merger with 4D pharma, a world leader in the development of Live Biotherapeutics, a novel and emerging class of drugs.  

$13.45  +0.25 (1.89%)
As of 03/19/2021 16:00:01 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Financials
Industry:  Shell Companies
Index country:  USA
Country of incorporation:  
IPO date:  10/16/2018
Outstanding shares:  2,625,622
Average volume:  47,631
Market cap:   $35,314,588
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   5.51
PS ratio:   0.00
Return on equity:   -11.72%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy